Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

This study has been completed.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00087425

Locations


United States, Maryland
	NIH - Warren Grant Magnuson Clinical Center
	Bethesda, Maryland, United States, 20892-1182

Sponsors and Collaborators

National Institute on Aging (NIA)

National Cancer Institute (NCI)

Investigators


Study Chair:	Igor Espinoza-Delgado, MD	Gerontology Research Center